SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001665
Filing Date
2023-02-14
Accepted
2023-02-14 09:30:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMBRX BIOPHARMA INC. p23-0720sc13ga.htm SC 13G/A 72131
  Complete submission text file 0000902664-23-001665.txt   73654
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92634 | Film No.: 23623432
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G/A